drugset / Trial / NCT00688428

Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

NCT00688428

Phase 1 Completed 84 enrolled AstraZeneca
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to test if fixed dose esomeprazole and ASA capsule is pharmaceutically equal to a free combination of esomeprazole capsule and ASA tablet

Timeline

Start
2008-04
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject ASA Unknown 325 mg Oral
Subject Esomeprazole Small molecule 40 mg Oral

Indications